Symbol="ALPN"
AssetType="Common Stock"
Name="Alpine Immune Sciences Inc"
Description="Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune / inflammatory disorders, and other diseases. The company is headquartered in Seattle, Washington."
CIK="1626199"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="201 ELLIOTT AVE. WEST, SUITE 230, SEATTLE, WA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="510356000"
EBITDA="-65693000"
PERatio="None"
PEGRatio="0"
BookValue="3.55"
DividendPerShare="0"
DividendYield="0"
EPS="-1.69"
RevenuePerShareTTM="0.684"
ProfitMargin="-2.459"
OperatingMarginTTM="-2.567"
ReturnOnAssetsTTM="-0.167"
ReturnOnEquityTTM="-0.446"
RevenueTTM="25822000"
GrossProfitTTM="-40179000"
DilutedEPSTTM="-1.69"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.311"
AnalystTargetPrice="15"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="9.42"
PriceToBookRatio="1.524"
EVToRevenue="1.385"
EVToEBITDA="-0.857"
Beta="1.237"
num_52WeekHigh="12.04"
num_52WeekLow="4.82"
num_50DayMovingAverage="9.43"
num_200DayMovingAverage="7.77"
SharesOutstanding="47965800"
DividendDate="2017-07-25"
ExDividendDate="None"
symbol="ALPN"
open="10.10"
high="10.78"
low="10.02"
price="10.64"
volume="93978.00"
latest_trading_day="2023-07-05"
previous_close="10.14"
change="0.50"
change_percent="4.9310%"
aroon_positive_momentum_days="68"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="68"
Volume_recent_avg="142617"
Change_recent_avg="0.03"
Delta_recent_avg="0.49"
Variance_recent_avg="0.24"
Change_ratio_recent_avg="0.31"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="68"
Aroon_momentum_negative="32"
image_negative_thumbnail_id_1="114"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0062.jpeg"
image_negative_thumbnail_id_2="100"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0076.jpeg"
image_neutral_thumbnail_id_1="549"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_neutral_thumbnail_id_2="589"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0010.jpeg"
image_positive_thumbnail_id_1="661"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0047.jpeg"
image_positive_thumbnail_id_2="677"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0031.jpeg"
image_professor_thumbnail_id_1="1176"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
